Member Info for lambo222

Well if that’s not a red flag I don’t know what is! Looks very very likely now that Kobold are either pulling out of the JV or not drilling this year if the CLN holder didn’t want to know even at 2.5p. Placing on the way absolute shambles

I can’t see them doing anything at Disko this year, it’s May in a couple of weeks and radio silence, the problem with Disko is exploration is very expensive maybe Kobold just look at Zambia and think, low cost, easy to build a mine good weather, Disko for all its potential May just be too harsh when there are easier places to explore at a fraction of the cost

Glad the rumours proved to be incorrect, but 7th June is a long way off, if it drops back to the 2p level I will probably average down, roses fast but also falls fast when volumes are low like now

I havnt changed my tune there has been £120k worth of sells this morning so something is clearly up

Rumours of submission rejection, very much hope this is not true! Huge selling today

If they don’t drill at Disko this year then this will be back at 2.5p and below sharpish, leaving it very very late now given the amount of planning needed to drill in a short summer window

Where is the FDA date rns?? FDA guidelines state 21 days which expired on Friday, We cannot afford any more issues or delays, the better not have messed it up again

Holding very well at this level, big move up towards 5p coming on FDA date rns imo

I would not even consider selling any until 5p is breached, FDA meeting date is imminent which should really get the momentum going here

Not many sellers at this low level, this traded at 7p ahead of last years FDA meeting, as we build up to the meeting over the next few weeks history will repeat imo and the price will head towards 7p yet again, and this time we have the CIDP FDA approval meeting to look forward to on 16th May, also news of Avion collaboration overdue and 5p warrants expiring on 10th June, you can see exactly where the price is going, 3p is long gone

Well the same google finance shows the price going from 22p to 170p during the last phase 3 trial of Lupozor and a £250m mcap… currently at £10m mcap with two phase 2/3 trials now at the FDA approval stage targeting multi billion $ markets. Opportunity knocks from the companies with the lowest valuations and the highest blue sky potential, the fact Avion we’re happy to put £1.1m in at 11p shows the value they see in IMM. Warrants kick in at 5p, something tells me 5p will be hit and soon given L1 and Lind warrants expire 10th June they will want the price above 5p before they expire imo, TGI’s company has a habit or re rating once momentum is with it, we are right at the beginning of the upward curve imo

Alongside the blockbuster potential of Lupozor for Lupus and the CIDP trials both of which target multi billion $ markets we also have the recently announced partnership with Orano which does look particularly exciting.
Key points:



· Orano has paid a small undisclosed amount to ImmuPharma for a 12-month collaboration to identify suitable radiotherapy candidates for the treatment of cancer.

· ImmuPharma has agreed to provide its peptide technology, to explore the potential to allow delivery of a potent radioactive isotope to the core of a cancer cell.

· Our team based in Bordeaux, (ImmuPharma Biotech), in conjunction with Orano and the Cancer Research Centre of Lyon (CRCL), will work together to identify molecules that can carry the radioactive entity.

· Any potential new cancer therapeutic using ImmuPharma's peptide technology, discovered as part of the collaboration will be subject to a full licensing agreement between ImmuPharma and Orano in preparation for further development by Orano.

· The therapeutic goal is to use ImmuPharma's peptide technology to deliver a radioactive bullet to the nucleus of cancer cells, killing the cell with minimal impact on surrounding tissue.

· The radiopharmaceuticals market is expected to achieve global sales *€8.5bn by 2031. The combination of ImmuPharma's peptide technology and a powerful radioactive bullet is an exciting new approach with significant commercial potential.

Could easily get back above 20p if both phase 2/3 trials are approved over the next few weeks at their separate FDA meetings, both Lupus and CIDP have multi billion $ markets and the Lupus trial will be funded by Avion for $25m, my hunch is once the CIDP trial is approved IMM will sell a portion of the rights for a large cash lump sum, this was alluded to by the CEO in his last interview… exciting few weeks ahead here

Should be back at 5p when they release the FDA date next week momentum is only just beginning here any significant volume and it will really motor

Sold today when FDA decision date for Lupus phase 3 trial is due to be announced next week? Historically the share price has climbed significantly leading up to the FDA meeting date and the price is at historically low levels, I would suggest the time to derisk would be before the FDA decision date by which time the price will likely be over 5p, but at least you kept some

It’s called trading, bought back in at 2.4p average as the CIDP trial news is a game changer

The meeting to get excited about is the FDA type C meeting to approve Lupozor phase 2/3 trial funded for $25m by Avion. We should get the date for this meeting early date meet assuming the date will be late May. If approvals are given this will be sat back above 10p imo and very much game on after a long spell out in the cold, a successful phase 3 trial and the Mcap here will be well north of £200m , all to play for

L1 5p warrants expire in June I think be nice to get to 5p before FDA decision date shouldn’t be too difficult any volume and it will move up very quickly imo

Should get confirmation of the FDA decision date for the Lupus phase 2/3 trial funded by Avion for $25m within the next few days, as we build up to the date I can see this comfortably above 5p where the options will kick in, FDA approval and we should be sat at 10p by early June imo, GL all holders we should be in for quite a ride

It’s a Lanstead death spiral, what else do investors expect, will drift back to 1.5p range now as no news expected for a few months all the while Lanstead are selling into low liquidity the only way is down I’m afraid until they do a proper placing to clear Lanstead once and for all